Mental Health

Caplyta is an oral, once daily medicine approved for the treatment of schizophrenia in adults.

Top news from across the health care landscape.

As accessible health providers, pharmacists are well positioned to assist young people who have mental health issues.

Medication adherence is essential to avoid serious consequences, such as attempted suicide.

Megan Maroney, PharmD, BCPP, clinical associate professor, Ernest Mario School of Pharmacy at Rutgers, the State University of New Jersey; clinical psychiatric pharmacist, Monmouth Medical Center, Long Branch, NJ, discusses how to navigate data on medications with higher risks of suicidality and depression.

Megan Maroney, PharmD, BCPP, clinical associate professor, Ernest Mario School of Pharmacy at Rutgers, the State University of New Jersey; clinical psychiatric pharmacist, Monmouth Medical Center, Long Branch, New Jersey, discusses several risk factors for patients on medications with higher risks of suicidality and depression.

Megan Maroney, PharmD, BCPP, clinical associate professor, Ernest Mario School of Pharmacy at Rutgers, the State University of New Jersey; clinical psychiatric pharmacist, Monmouth Medical Center, Long Branch, NJ, explains several tips for safely monitoring patients who are on medications with higher risks of suicidality and depression.

Almost one-third of those who suffer are treatment resistant, which can pose challenges.

PTSD can have debilitating effects, including flashbacks, nightmares, and extreme anxiety.

Megan Maroney, PharmD, BCPP, clinical associate professor, Ernest Mario School of Pharmacy at Rutgers, the State University of New Jersey; clinical psychiatric pharmacist, Monmouth Medical Center, Long Branch, NJ, discusses the higher risk for potential adverse effects of suicidal ideation and behavior, and depression in younger patients.

The researchers found that the likelihood of being hospitalized for a somatic disease was just as high during the periods when the patients were on antipsychotic drugs as when they were not; however, the differences in mortality were clear.

Hemophagocytic lymphohistiocytosis (HLH) induced by lamotrigine was recently an active topic on social media, with users following a recent article that reported an Austin, Texas detective had died from the condition in 2018.

Megan Maroney, PharmD, BCPP, clinical associate professor, Ernest Mario School of Pharmacy at Rutgers, the State University of New Jersey; clinical psychiatric pharmacist, Monmouth Medical Center, Long Branch, NJ, discusses the higher risk for potential adverse effects of suicidal ideation and behavior, and depression in younger patients.

Officials with the FDA have approved Intra-Cellular Therapies’ lumateperone (Caplyta) for the treatment of schizophrenia in adults, according to the company.

Many individuals with HIV who are receiving antiretroviral therapy have viral genetic material in the cells of their cerebrospinal fluid, making them more likely to experience memory and concentration problems, according to the results of a new study.

The FDA has granted Fast Track Designation for the development of PH94B (VistaGen Therapeutics), a neuroactive nasal spray for on-demand treatment of social anxiety disorder (SAD).

In addition to handling issues such as depression, post-traumatic stress disorder, suicide screenings, and anxiety, many mental health pharmacists deal with typical metabolic conditions, such as hypertension and diabetes.

Exercise improves psychological, behavioral, neurobiological, and overall health of patients.

Suicide rates in the United States increased in nearly every state between 1999 and 2016. More than half of the states had a more than 30% rise in suicides during that period. In 2016, nearly 45,000 lives were lost to suicide.

Officials from the FDA have approved Noven Pharmaceuticals, Inc.’s asenapine (Secuado) transdermal system, which is the first-and-only transdermal patch for the treatment of adults with schizophrenia, according to the company.

A recent study has revealed that just under half of the US population fears random mass shootings and terrorist attacks.

The Pacific Ketamine Institute is now offering esketamine nasal spray (Spravato, Johnson & Johnson) for the treatment of patients who don't respond well to traditional oral antidepressants. It is a prescription medication to be used alongside an oral antidepressant.1

The FDA has approved Zulresso (brexanolone), from Sage Therapeutics, injection to treat postpartum depression (PPD) in adults.1

NAMI Basics OnDemand is an adaptation of the in-person NAMI Basics, a free, 6-session education program for parents, caregivers, and other family who provide care for adolescents aged 22 years or younger who are experiencing mental health symptoms.

The study aimed to determine the association between antidepressant classes, types, and duration of use during pregnancy and the risk of gestational diabetes.